Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 90, Number 7, 1 July 2015

Myelodysplastic syndrome with clonal cytogenetic abnormalities followed by fatal erythroid leukemia after 14 years of exposure to hydroxyurea for sickle cell anemia
pp. E131-E132(2)
Authors: Aumont, Cédric; Driss, Françoise; Lazure, Thierry; Picard, Véronique; Creidy, Rita; De Botton, Stéphane; Saada, Véronique; Lambotte, Olivier; Bilhou‐Nabera, Chrystèle; Tertian, Gérard; Michot, Jean‐Marie

Favourites:
ADD

Long‐term safety follow‐up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation
pp. E133-E134(2)
Authors: Jaspers, Aurélie; Baron, Frédéric; Maertens, Johan; De Prijck, Bernard; Schots, Rik; Bonnet, Christophe; Hafraoui, Kaoutar; Willems, Évelyne; Servais, Sophie; Fillet, Georges; Beguin, Yves

Favourites:
ADD

Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission
pp. E134-E135(2)
Authors: Takahashi, Koichi; Roh, Whijae; Zhang, Jianhua; Propotopov, Alexei; Patel, Keyur; Strickland, Stephen; Kim, Annette; Vnencak‐Jones, Cindy; Pelletier, Sarah; Parmar, Simrit; Garcia‐Manero, Guillermo; Kornblau, Steven; Chin, Lynda; Kantarjian, Hagop; Futreal, P. Andrew; Ravandi, Farhad

Favourites:
ADD

Combination of EUTOS score and 3‐month BCR‐ABL transcript level identifies a group of good‐risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy
pp. E135-E137(3)
Authors: Tiribelli, Mario; Binotto, Gianni; Calistri, Elisabetta; Maino, Elena; Scaffidi, Luigi; Medeot, Marta; Nabergoj, Mitja; Ambrosetti, Achille; Semenzato, Gianpietro; Fanin, Renato; Bonifacio, Massimiliano; for the Gruppo Triveneto LMCajh24022-cr-0012

Favourites:
ADD

Lu/BCAM‐mediated cell adhesion as biological marker of JAK2V617F activity in erythrocytes of polycythemia vera patients
pp. E137-E138(2)
Authors: De Grandis, Maria; Cassinat, Bruno; Kiladjian, Jean‐Jacques; Chomienne, Christine; El Nemer, Wassim

Favourites:
ADD

Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels
pp. E138-E139(2)
Authors: Adekile, Adekunle; Menzel, Stephan; Gupta, Renu; Al‐Sharida, Sondus; Farag, Asma; Haider, Mohammad; Akbulut, Nagihan; Mustafa, Nada; Thein, Swee Lay

Favourites:
ADD

Decitabine improves outcomes in older patients with acute myeloid leukemia and higher blast counts
pp. E139-E141(3)
Authors: Kadia, Tapan M.; Thomas, Xavier G.; Dmoszynska, Anna; Wierzbowska, Agnieszka; Minden, Mark; Arthur, Christopher; Delaunay, Jacques; Ravandi, Farhad; Kantarjian, Hagop

Favourites:
ADD

Dramatic erythroid response to low‐dose thalidomide in two patients with transfusion independent thalassemia and severe post‐transfusional alloimmune hemolysis
pp. E141-E141(1)
Authors: Fozza, Claudio; Pardini, Simonetta; Giannico, Domenica Barbara; Targhetta, Clara; Di Tucci, Anna Angela; Dessalvi, Paolo; Angelucci, Emanuele; Dore, Fausto

Favourites:
ADD

Seven‐year safety and efficacy with velaglucerase alfa for treatment‐naïve adult patients with type 1 Gaucher disease
pp. 577-583(7)
Authors: Zimran, Ari; Wang, Nan; Ogg, Carol; Crombez, Eric; Cohn, Gabriel M.; Elstein, Deborah

Favourites:
ADD

Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long‐term data from phase III clinical trials
pp. 584-591(8)
Authors: Hughes, Derralynn A.; Gonzalez, Derlis E.; Lukina, Elena A.; Mehta, Atul; Kabra, Madhulika; Elstein, Deborah; Kisinovsky, Isaac; Giraldo, Pilar; Bavdekar, Ashish; Hangartner, Thomas N.; Wang, Nan; Crombez, Eric; Zimran, Ari

Favourites:
ADD

Safety and efficacy results of switch from imiglucerase to velaglucerase alfa treatment in patients with type 1 Gaucher disease
pp. 592-597(6)
Authors: Elstein, Deborah; Mehta, Atul; Hughes, Derralynn A.; Giraldo, Pilar; Charrow, Joel; Smith, Laurie; Shankar, Suma P.; Hangartner, Thomas N.; Kunes, Yune; Wang, Nan; Crombez, Eric; Zimran, Ari

Favourites:
ADD

Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND study
pp. 598-601(4)
Authors: Brynes, Russell K.; Orazi, Attilio; Theodore, Dickens; Burgess, Paul; Bailey, Christine K.; Thein, Maung M.; Bakshi, Kalpana K.

Favourites:
ADD

WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides
pp. 602-607(6)
Authors: Brayer, Jason; Lancet, Jeffrey E.; Powers, John; List, Alan; Balducci, Lodovico; Komrokji, Rami; Pinilla‐Ibarz, Javier

Favourites:
ADD

Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin‐induced thrombocytopenia‐reactive antibodies or with true HIT (HIT‐reactive antibodies plus thrombocytopenia): An 11‐year experience
pp. 608-617(10)
Authors: Palatianos, George; Michalis, Alkiviadis; Alivizatos, Petros; Lacoumenda, Stavroula; Geroulanos, Stefanos; Karabinis, Andreas; Iliopoulou, Eugenia; Soufla, Giannoula; Kanthou, Chryso; Khoury, Mazen; Sfyrakis, Petros; Stavridis, George; Astras, George; Vassili, Maria; Antzaka, Christina; Marathias, Katerina; Kriaras, Ioannis; Tasouli, Androniki; Papadopoulos, Kyrillos; Katafygioti, Marina; Matoula, Nikoletta; Angelidis, Antonios; Melissari, Euthemia

Favourites:
ADD

A single high‐resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low‐resolution HLA mismatch
pp. 618-623(6)
Authors: Fuji, Shigeo; Kanda, Junya; Kato, Shunichi; Ikegame, Kazuhiro; Morishima, Satoko; Miyamoto, Toshihiro; Hidaka, Michihiro; Kubo, Kohmei; Miyamura, Koichi; Tsudo, Mitsuru; Kobayashi, Hikaru; Maesako, Yoshitomo; Eto, Tetsuya; Adachi, Souichi; Ichinohe, Tatsuo; Atsuta, Yoshiko; Kanda, Yoshinobu; on behalf of the HLA Working Group of the Japan Society for Hematopoietic Cell Transplantationajh24028-cr-0018

Favourites:
ADD

Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation
pp. 624-628(5)
Authors: Esrick, Erica B.; McConkey, Marie; Lin, Katherine; Frisbee, Alyse; Ebert, Benjamin L.

Favourites:
ADD

Pitfalls in the diagnosis of heparin‐Induced thrombocytopenia: A 6‐year experience from a reference laboratory
pp. 629-633(5)
Authors: Nazi, Ishac; Arnold, Donald M.; Moore, Jane C.; Smith, James W.; Ivetic, Nikola; Horsewood, Peter; Warkentin, Theodore E.; Kelton, John G.

Favourites:
ADD

Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5‐year long‐term Italian multicenter randomized clinical trial
pp. 634-638(5)
Authors: Calvaruso, Giuseppina; Vitrano, Angela; Di Maggio, Rosario; Lai, Eliana; Colletta, Grazia; Quota, Alessandra; Gerardi, Calogera; Rigoli, Luciana Concetta; Sacco, Massimiliano; Pitrolo, Lorella; Maggio, Aurelio

Favourites:
ADD

Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old
pp. 639-646(8)
Authors: Gupta, Neha; Miller, Austin; Gandhi, Shipra; Ford, Laurie A.; Vigil, Carlos E.; Griffiths, Elizabeth A.; Thompson, James E.; Wetzler, Meir; Wang, Eunice S.

Favourites:
ADD

Bortezomib‐based therapy combined with high cut‐off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment
pp. 647-652(6)
Authors: Zannetti, Beatrice Anna; Zamagni, Elena; Santostefano, Marisa; De Sanctis, Lucia Barbara; Tacchetti, Paola; Mancini, Elena; Pantani, Lucia; Brioli, Annamaria; Rizzo, Raffaella; Mancuso, Katia; Rocchi, Serena; Pezzi, Annalisa; Borsi, Enrica; Terragna, Carolina; Marzocchi, Giulia; Santoro, Antonio; Cavo, Michele

Favourites:
ADD

ASXL1 mutations are frequent and prognostically detrimental in CSF3R‐mutated chronic neutrophilic leukemia
pp. 653-656(4)
Authors: Elliott, Michelle A.; Pardanani, Animesh; Hanson, Curtis A.; Lasho, Terra L.; Finke, Christy M.; Belachew, Alem A.; Tefferi, Ayalew

Favourites:
ADD

Management of chronic lymphocytic leukemia (CLL) in the era of B‐cell receptor signal transduction inhibitors
pp. 657-664(8)
Authors: Mato, Anthony; Jauhari, Shekeab; Schuster, Stephen J.

Favourites:
ADD

The aggressive peripheral T‐cell lymphomas: 2015
pp. 665-673(9)
Author: Armitage, James O.

Favourites:
ADD

The complex morphology of acute kidney injury with microangiopathic hemolytic anemia and hyposplenism
pp. 674-674(1)
Authors: Erblich, Thomas; Hill, Peter D.; Tomlinson, James; Bain, Barbara J

Favourites:
ADD

Severe and persistent heparin‐induced thrombocytopenia despite fondaparinux treatment
pp. 675-678(4)
Authors: Tvito, Ariella; Bakchoul, Tamam; Rowe, Jacob M.; Greinacher, Andreas; Ganzel, Chezi

Favourites:
ADD

Corticosteroid‐induced morphological changes in cells of the myeloid lineage
pp. 679-680(2)
Authors: Lee, Sunyoung; Khankhanian, Pouya; Mascarenhas, John O.

Favourites:
ADD

False‐negative FDG‐PET in histologically proven extensive large cell bone marrow involvement in diffuse large B‐cell lymphoma
pp. 681-681(1)
Authors: Adams, Hugo J.A.; de Klerk, John M.H.; Fijnheer, Rob; Dubois, Stefan V.; Nievelstein, Rutger A.J.; Kwee, Thomas C.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more